ES, B., J, M., S, W., Y, G., E, P., AE, K., . . . MR, B. (2005). Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. The Journal of pharmacology and experimental therapeutics, 315(3), 1278. https://doi.org/10.1124/jpet.105.092155
Chicago Style (17th ed.) CitationES, Burstein, et al. "Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-desmethylclozapine as a D2/D3 Partial Agonist." The Journal of Pharmacology and Experimental Therapeutics 315, no. 3 (2005): 1278. https://doi.org/10.1124/jpet.105.092155.
MLA (9th ed.) CitationES, Burstein, et al. "Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-desmethylclozapine as a D2/D3 Partial Agonist." The Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 3, 2005, p. 1278, https://doi.org/10.1124/jpet.105.092155.